|Articles|February 1, 2002

Daptomycin impressive against dual staph, strep skin infections

Chicago - Daptomycin (Cidecin), a novel lipopeptide antibiotic, showed a trend toward an improved clinical response compared to current standard therapy in the treatment of complicated skin and soft tissue (cSST) infections caused by dual infection with

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME